Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06271707

Stellate Ganglion Block

Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.

Conditions

Interventions

TypeNameDescription
DRUG0.5% bupivacainean ultrasound guided left stellate ganglion block with 5 mL of 0.5% bupivacaine
OTHERSalinean ultrasound guided left stellate ganglion block with 5 mL of saline

Timeline

Start date
2025-05-19
Primary completion
2027-04-15
Completion
2027-07-15
First posted
2024-02-22
Last updated
2025-09-04

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06271707. Inclusion in this directory is not an endorsement.

Stellate Ganglion Block (NCT06271707) · Clinical Trials Directory